Literature DB >> 21308534

Diagnosing Vaginal Infections: It's Time to Join the 21st Century.

Barbara Van Der Pol1.   

Abstract

Vaginal infections are one of the most common reasons for medical healthcare visits in the United States and Western Europe. These diseases are also significantly associated with HIV acquisition in resource-constrained settings throughout the world. However, despite ample opportunity to improve diagnosis, and therefore management, of vaginitis and vaginosis, the healthcare community continues to rely on diagnostic methods with poor performance characteristics. This state of affairs results in part from the lack of a public health mandate to reduce the burden of these infections in women. Without such a mandate, there is a lack of funding for reimbursement for more sensitive and specific diagnostic assays. Sensitive assays do exist for these infections, and their use should be encouraged when appropriate for clinical care.

Entities:  

Year:  2010        PMID: 21308534     DOI: 10.1007/s11908-010-0096-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  31 in total

1.  Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa.

Authors:  J A Frohlich; Q Abdool Karim; M M Mashego; A W Sturm; S S Abdool Karim
Journal:  J Adv Nurs       Date:  2007-09-06       Impact factor: 3.187

2.  Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis.

Authors:  M H Levi; J Torres; C Piña; R S Klein
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

Authors:  Barbara Van Der Pol; James A Williams; Donald P Orr; Byron E Batteiger; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2005-11-08       Impact factor: 5.226

4.  Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.

Authors:  C S Bradshaw; A N Morton; S M Garland; L B Horvath; I Kuzevska; C K Fairley
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Temporal associations with declining Trichomonas vaginalis diagnosis rates among women in the state of Victoria, Australia, 1947 to 2005.

Authors:  John Marrone; Christopher K Fairley; Marian Saville; Catriona Bradshaw; Francis J Bowden; Leonie B Horvath; Basil Donovan; Marcus Chen; Jane S Hocking
Journal:  Sex Transm Dis       Date:  2008-06       Impact factor: 2.830

6.  Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs.

Authors:  Maureen Miller; Yuyan Liao; Anu Manchikanti Gomez; Charlotte A Gaydos; Delysha D'Mellow
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

7.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

8.  Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard.

Authors:  Nancy K Lowe; Jeremy L Neal; Nancy A Ryan-Wenger
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

9.  Disentangling contributions of reproductive tract infections to HIV acquisition in African Women.

Authors:  Janneke H H M van de Wijgert; Charles S Morrison; Joelle Brown; Cynthia Kwok; Barbara Van Der Pol; Tsungai Chipato; Josaphat K Byamugisha; Nancy Padian; Robert A Salata
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

10.  Targeted screening for Trichomonas vaginalis in women, a pH-based approach.

Authors:  Charlotte Bell; Emma Hough; Alan Smith; Linda Greene
Journal:  Int J STD AIDS       Date:  2007-06       Impact factor: 1.359

View more
  5 in total

1.  Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women.

Authors:  Charles P Cartwright; Bryndon D Lembke; Kalpana Ramachandran; Barbara A Body; Melinda B Nye; Charles A Rivers; Jane R Schwebke
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

2.  Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.

Authors:  Toril Andersen; Ekaterina Mishchenko; Gøril Eide Flaten; Johanna U Ericson Sollid; Sofia Mattsson; Ingunn Tho; Nataša Škalko-Basnet
Journal:  Mar Drugs       Date:  2017-03-04       Impact factor: 5.118

3.  Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population.

Authors:  Stacey J Ackerman; Tyler Knight; Peter M Wahl; Charles P Cartwright
Journal:  Clinicoecon Outcomes Res       Date:  2019-02-20

4.  Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.

Authors:  Jane R Schwebke; Stephanie N Taylor; Ronald Ackerman; Robert Schlaberg; Neil B Quigley; Charlotte A Gaydos; Steven E Chavoustie; Paul Nyirjesy; Carmelle V Remillard; Philip Estes; Byron McKinney; Damon K Getman; Craig Clark
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

5.  Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness.

Authors:  Haywood Brown; Madeline Drexler
Journal:  Popul Health Manag       Date:  2020-10       Impact factor: 2.459

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.